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Value of the data {#sec0001}
=================

•Our prospectively collected data may be useful for clinicians and researchers working in the fields of thoracic surgery or pneumology. The data may also be useful for pain research.•The data provide an insight in details of pain medication after lung surgery.•The dataset provides a valuable starting point for further prospective studies in the field of thoracic surgery.

Data description {#sec0002}
================

This dataset contains rare data of a surgical cohort with PAL treated with autologous blood patch pleurodesis or watch and wait. We evaluated postoperative patient data on a daily basis, starting with the first postoperative day and up to 10 days postoperatively. This corresponds to day 5 after randomization. The dataset includes baseline data like gender, age, pain medication on discharge and pre-existing pain medication as well ([Table 1](#tbl0001){ref-type="table"}).Tab. 1Patient characteristics.Tab 1:Group A (*n* = 10)Group B (*n* = 14)Female/Male2/86/8Median age65.6 years (range 50.4--78)66.6 years (range 56.2--79.1)Pain Medication on dischargeOpioid[\*](#tb1fn1){ref-type="table-fn"} plus NSAR 6Opioid[\*](#tb1fn1){ref-type="table-fn"} plus NSAR 7NSAR only 4NSAR only 4None 0None 3Pre-existing pain medicationOpioid 1None 14None 9[^1]

[Fig. 1](#fig0001){ref-type="fig"} ([Fig. 1](#fig0001){ref-type="fig"}) shows pain scores (VAS, visual analog scale) from the first postoperative day until the tenth day after the operation. On day five randomization was performed. Pain levels between both groups did not differ. Pain levels were evaluated with both arms in resting position (watch and wait vs. autologous blood patch pleurodesis, not significant).Fig. 1 Fig 1

[Fig. 2](#fig0002){ref-type="fig"} ([Fig. 2](#fig0002){ref-type="fig"}) shows pain scores (VAS, visual analog scale) from the first postoperative day until the tenth day after the operation. On day five randomization was performed. Pain levels between both groups did not differ. Pain levels were evaluated while moving both arms (watch and wait vs. autologous blood patch pleurodesis, not significant).Fig. 2 Fig 2

At the first day after operation median pain score in resting position was 1 (range 0 to 4) in the watch and wait arm. On same day median pain score was 0 (range 0 to 3) if patients received autologous blood pleurodesis. From day two until the 10th day after the operation the median pain score was between 4 (range 0 to 10) and 3 (range 0 to 10) in both arms. ([Table 2](#tbl0002){ref-type="table"})Table 2.Table 2ArmWatch and waitAutologous blood pleurodesisNMinimumMaximumMeanMedianSDRSD25 - 75 PNMinimumMaximumMeanMedianSDRSD25 - 75 PDay 1140,0004000135715001,15070,84790,000 to 2000100,00030000,7780,0001,09291,40520,000 to 1250Day 21420009000478645002,15470,45024000 to 6000100,0008000488950002,47210,50563750 to 7000Day 3140,0006000328635002,01640,61372000 to 5000100,0005000366740001,73210,47242750 to 5000Day 4140,0007000385740001,95560,50703000 to 5000100,0005000300040001,80280,60092250 to 4000Day 5\
(Randomization)140,00010,000435740002,73460,62763000 to 600010200010,000455640002,35110,51613000 to 5250Day 61410008000428640001,97790,46153000 to 60001030008000433340001,65830,38273000 to 5000Day 71410008000385730001,79130,46443000 to 5000100,00010,000411130002,75880,67113000 to 5250Day 8140,0008000357130002,13810,59873000 to 50001020008000422230002,16670,51322750 to 5500Day 91410008000407135002,23480,54893000 to 6000100,0009000422240002,68220,63532750 to 5500Day 101410007000364330001,73680,47683000 to 5000100,0008000344430002,18580,63462750 to 4250

Median pain score on first day after the operation when moving was 5 (range 0 to 10) in the watch and wait group and 4 (range from 0 to 8) in the blood pleurodesis group. Between the second and the 10th day after operation median pain score when moving was between 0 (range 0 to 5) and 2 (range 0 to 10). [Table 3](#tbl0003){ref-type="table"}.Table 3.Table 3ArmWatch and waitAutologous blood pleurodesisNMinimumMaximumMeanMedianSDRSD25 - 75 PNMinimumMaximumMeanMedianSDRSD25 - 75 PDay 1140,00010,000457150002,65200,58013000 to 6000100,0008000388940003,01850,77621500 to 6250Day 2140,0003000114310001,02710,89870,000 to 2000100,00030000,8890,0001,36421,53480,000 to 2250Day 3140,000500010000,0001,51911,51910,000 to 2000100,00030000,7780,0001,09291,40520,000 to 1250Day 4140,0004000128610001,43731,11790,000 to 2000100,00030000,7780,0001,20191,54520,000 to 2000Day 5\
(Randomization)140,000400010710,0001,43921,34330,000 to 2000100,00010,000255620003,00461,17570,750 to 3000Day 6140,00030000,7140,0001,06901,49670,000 to 2000100,0005000177820001,71590,96520,000 to 3000Day 7140,0003000107110001,07161,00020,000 to 2000100,000700013330,0002,39791,79840,000 to 2250Day 8140,0004000121410001,18830,97860,000 to 2000100,000500013330,0001,93651,45240,000 to 2500Day 9140,0003000107110001,07161,00020,000 to 2000100,00040000,5560,0001,33332,40000,000 to 0,250Day 10140,0003000107110001,14111,06510,000 to 2000100,00030000,7500,0001,16501,55330,000 to 1500

Experimental design, materials, and methods {#sec0003}
===========================================

Study design: Investigator initiated prospective randomized single-center study. Due to the type of intervention blinding was not performed. All patients who demonstrated a persistent air leakage at postoperative day 5 after pulmonary resection were screened for eligibility and asked for consent. Patients were then either randomized to receiving 100 ml autologous blood injected at postoperative days five and six (group A) or to watchful waiting (group B). In case of an expanded lung routinely no suction was applied, however the decision to apply suction in case of insufficient lung expansion was left to the decision of the consultant in charge. The drains were removed as soon as no air leakage was determined for 24 h and fluid production was \< 350 ml/24 h.

Routine management: At the end of surgery water seal test was performed to exclude air leakage. In case of observed air leakage all necessary measures were taken to close the fistula. Routinely Ch24 chest tubes were placed. The decision to place one or two chest tubes was depending on the intraoperative situation and the degree of adhesions as well as bleeding tendency. In standard anatomical lung resections usually one posteroapical drainage was used. Digital and conventional chest drainages were used depending on availability and surgeon preference. In standard lung resections -- 20 cm H2O suction was applied. In patients with severely emphysematous lungs and after lung volume reduction surgery no suction was used. The decision for drainage removal was based on absence of air leakage for 24 h and fluid production \<350 ml/24 h.

Blood patch pleurodesis: Blood patch with autologous blood was performed on ward in aseptic conditions and without any additional analgesia. A quantity of 100 ml blood was taken from a peripheral vein of the upper extremity in sterile conditions and injected immediately in the apical chest tube. No Heparin was added. If possible the chest tube was clamped for a period of 20 min otherwise the chest drain was elevated above the level of the patient´s chest, in order to keep the injected blood within the chest but allow air drainage.

The indication for surgical revision given if a collapsed lung in the chest X-ray despite suction combined with persistent air leakage was observed.

Pain assessment was conducted every day via visual analog scale. We assessed status of pain from the first postoperative day until the tenth day after operation.

Statistical analysis was conducted by using MedCalc software Version 11.6.1.0 (MedCalc software, Broekstraat 52, 9030 Mariakerke, Belgium). Pain score (VAS) was analysed by multivariat analysis (ANOVA). A Bonferroni corrected p value \<0.05 was considered as significant.
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[^1]: ***low potential opioid***.
